0.47% -0.1125

Atricure Inc (ATRC)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Atricure Inc Stock (ATRC) Company Profile

Atricure Inc

Healthcare (1136)

513-755-4100

7555 INNOVATION WAY, MASON, OH

최신 SEC 제출 서류

ATRC's Discussions on Twitter

ATRC을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ATRC Atricure Inc	40.62	2.03B	499.95M	-36.36M	24.22M	-0.77
ISRG Intuitive Surgical Inc	563.76	197.40B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	196.53	55.76B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	80.04	38.93B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	243.88	35.90B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	267.83	19.36B	2.96B	487.70M	344.00M	6.6758

Atricure Inc Stock (ATRC) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-12-17	재개	JP Morgan	Overweight
2024-04-23	업그레이드	Oppenheimer	Perform → Outperform
2023-10-23	개시	JMP Securities	Mkt Outperform
2023-09-29	개시	UBS	Buy
2021-08-05	다운그레이드	Oppenheimer	Outperform → Perform
2020-12-18	재확인	Needham	Buy
2020-11-06	재확인	Needham	Buy
2020-04-07	개시	Oppenheimer	Outperform
2020-02-06	개시	BTIG Research	Buy
2020-01-24	재확인	Needham	Buy
2019-08-13	다운그레이드	Northland Capital	Outperform → Market Perform
2019-04-12	개시	JP Morgan	Overweight
2018-10-04	재확인	Needham	Buy
2018-08-02	재확인	Needham	Buy
2018-08-02	재확인	Stifel	Buy
2018-06-18	재확인	Needham	Buy
2018-04-27	재확인	Needham	Buy
2018-01-16	재확인	Needham	Buy
2017-11-02	재확인	Needham	Buy
2017-07-28	재확인	Needham	Buy
2017-05-30	재개	Piper Jaffray	Overweight
2016-06-30	재개	JMP Securities	Mkt Outperform
2015-10-28	재확인	Needham	Buy
2015-10-06	재확인	Canaccord Genuity	Buy
2015-10-06	재확인	Needham	Buy

Atricure Inc 주식(ATRC)의 최신 뉴스

Atricure Inc (ATRC) 재무 분석

Atricure Inc (ATRC)

Atricure Inc Stock (ATRC) Company Profile

ATRC을(를) 다른 주식과 비교

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Atricure Inc 주식(ATRC)의 최신 뉴스

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference - BioSpace

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way? - 富途牛牛

JPMorgan Chase & Co. Boosts AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat

JP Morgan Raises AtriCure (ATRC) Price Target to $48 | ATRC Stoc - GuruFocus

AtriCure price target raised to $48 from $42 at JPMorgan - TipRanks

AtriCure, Inc. $ATRC Shares Acquired by Squarepoint Ops LLC - MarketBeat

AtriCure (ATRC) Is Up 6.3% After First Dual-Energy PFA–RFA Human Procedures Success - Sahm

AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human SuccessHas The Bull Case Changed? - Yahoo Finance

Loss Report: What valuation multiples suggest for AtriCure Inc stockJuly 2025 Outlook & Fast Entry Momentum Alerts - moha.gov.vn

AtriCure treats first patients with dual PFA/RF system - MedTech Dive

ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform - Finviz

Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year? - MSN

AtriCure reports first patients treated with dual-energy PFA, RF platform - MassDevice

AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - 01net

AtriCure, Inc. Announces the First Patients Treated with Novel Dual Energy Platform - marketscreener.com

AtriCure Reports 1st Treatments with Dual Energy RF, PFA System - Medical Product Outsourcing

AtriCure Says First Patients Treated With Dual-Energy Platform - marketscreener.com

AtriCure (ATRC) Introduces Cutting-Edge Dual Energy Platform in Initial Treatments - GuruFocus

AtriCure, Inc.'s (NASDAQ:ATRC) 29% Share Price Surge Not Quite Adding Up - simplywall.st

Russell Investments Group Ltd. Decreases Stake in AtriCure, Inc. $ATRC - MarketBeat

Are Medical Stocks Lagging AtriCure (ATRC) This Year? - Yahoo Finance

Hood River Capital Management LLC Has $100.31 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat

Will AtriCure Inc. stock deliver strong dividend growthPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser

Why analysts remain bullish on AtriCure Inc. stock2025 Trading Recap & Consistent Growth Stock Picks - Newser

AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - AOL.com

AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance - MSN

Geode Capital Management LLC Purchases 14,577 Shares of AtriCure, Inc. $ATRC - MarketBeat

How supply chain issues affect AtriCure Inc. stockJuly 2025 Volume & Scalable Portfolio Growth Methods - BỘ NỘI VỤ

Insider Selling: AtriCure (NASDAQ:ATRC) Director Sells 4,967 Shares of Stock - MarketBeat

Atricure Executives Make Significant Stock Sales - TipRanks

Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC) - GuruFocus

AtriCure Executives Engage in Stock Transactions - TradingView

Atricure Insider Sold Shares Worth $376,578, According to a Recent SEC Filing - MarketScreener

Dir Wehrwein Sells 10,000 ($376.6K) Of AtriCure Inc [ATRC] - TradingView

Officer Noznesky Sells 5,166 ($192.6K) Of AtriCure Inc [ATRC] - TradingView

ATRC Form 4: Director exercises $19.95 options, trims holdings - Stock Titan

[Form 4] AtriCure, Inc. Insider Trading Activity - Stock Titan

Precision Trading with Atricure Inc. (ATRC) Risk Zones - news.stocktradersdaily.com

Officer Noznesky Files To Sell 5,166 Of AtriCure Inc [ATRC] - TradingView

Atricure Director Makes a Significant Stock Sale! - TipRanks

AtriCure director Yuen sells $107k in shares By Investing.com - Investing.com Australia

Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade - Finviz

Insider Sell: Maggie Yuen Sells 3,000 Shares of AtriCure Inc (AT - GuruFocus

AtriCure director Yuen sells $107k in shares - Investing.com

AtriCure Director Maggie Yuen Sells 3,000 Shares - TradingView

Dir Wehrwein Files To Sell 5,033 Of AtriCure Inc [ATRC] - TradingView

Atricure Inc (ATRC) 재무 분석

매출

순이익

현금흐름

주당 순 이익

ATRC과 유사한 종목